NCT02813525

Brief Summary

Fetuses with IUGR, there is a correlation between Doppler indices of cardiovascular function and perinatal mortality. An index of systolic flow velocities at the aortic isthmus (ISI) has previously been described in a population of normal fetuses. Fetuses with IUGR, the velocities recorded in the aortic isthmus could be affected and the normal development of the ISI should be changed, because of the increase in placental resistance on one hand, and the gradual deterioration ventricular functions on the other one. Investigators hypothesize that the ISI index in the context of placental insufficiency could provide additional arguments on the extraction timing, the prognosis and the fetal extraction mode to severe hypoxia. The primary outcome of the study is to evaluate in an exploratory manner the feasibility and the potential interest of longitudinal monitoring of fetuses with IUGR by Doppler systolic isthmus and the calculation of the ISI index.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
320

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 15, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 27, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2016

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
Last Updated

June 27, 2016

Status Verified

June 1, 2016

Enrollment Period

2 years

First QC Date

June 15, 2016

Last Update Submit

June 22, 2016

Conditions

Keywords

Aortic IsthmusIsthmic Systolic Indexfeasibilityreproducibilitymortalitydelivery

Outcome Measures

Primary Outcomes (1)

  • Compare the evolution of the values of the ISI in the fetus with IUGR relative to those of fetuses without IUGR fetuses for the same gestational age

    Up to 3 months

Secondary Outcomes (3)

  • Assess the feasibility of the Doppler and the measure of the parameter

    Up to 3 months

  • Compare the reproducibility of the measurement between sonographers with different levels of expertise

    Up to 3 months

  • Estimate the association between ISI index and perinatal mortality and the performance of the ISI in predicting perinatal mortality

    Up to 3 months

Study Arms (2)

IUGR group

estimated fetal weight \<10th percentile associated with an abnormal umbilical artery Doppler with IP\>95th percentile or a confirmation of placental vascular disease by histological examination

Other: ISI index on Doppler systolic flow in the aortic isthmus

CONTROL group

non IUGR fetuses for gestational age (normal for weight, Doppler, and structural analyse)

Other: ISI index on Doppler systolic flow in the aortic isthmus

Interventions

Measure of the ISI index on Doppler systolic flow in the aortic isthmus in the follow-up by ultrasound of the fetus

CONTROL groupIUGR group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with vascular IURG fetuses and patients with non-IUGR fetuses.

You may qualify if:

  • Gestational age determined by ultrasound dating of the first quarter
  • IUGR group: estimated fetal weight \<10th percentile associated with
  • An abnormal umbilical artery Doppler with pulsatility index \>95th percentile
  • OR a confirmation of placental vascular disease by histological examination
  • CONTROL group: non IUGR fetuses for gestational age (normal for weight, Doppler, and structural analyse)

You may not qualify if:

  • Twin or multiple pregnancy,
  • Fetal weight\> 10th percentile
  • Presence of fetal infection
  • Structural fetal anomaly or fetal chromosomal abnormality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de gynécologie-obstétrique et de médecine fœtale

Bordeaux, France

Location

Study Officials

  • Paul PEREZ, MD

    University Hospital Bordeaux, France

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2016

First Posted

June 27, 2016

Study Start

September 1, 2016

Primary Completion

September 1, 2018

Study Completion

September 1, 2018

Last Updated

June 27, 2016

Record last verified: 2016-06

Locations